NASD · Healthcare · Diagnostics & Research · USA
Idexx Laboratories Inc is a large cap company (market value between $10 billion and $200 billion) in the Diagnostics & Research industry.
IDEXX Laboratories develops, manufactures, and distributes veterinary diagnostic products and services, water testing solutions, and livestock health products. The company offers point-of-care diagnostic instruments and consumables for companion animal practices, reference laboratory services, practice management software, and diagnostic imaging systems. It also provides water quality testing products and human medical point-of-care diagnostics.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Idexx Laboratories Inc stock.
Overvalued: intrinsic value $249.79 per share, market price $555.80, margin of safety -122.5% (as of 2026-10-19).
Discounting its cash flows at 11.9% (average of 3 methods) values the shares at $249.79; the price of $555.80 is 123% above that value, and 67% of that value comes from beyond year five.
Leak Score: 75/100 on 12 of 12 signals (Clear Leak).
17 more funds hold it; the full list is part of the paid plan.
All 44 Diagnostics & Research stocks
8 more in this industry show a wider margin of safety.
IDXX is overvalued (as of the 2026-10-19 close). Discounting its cash flows at 11.9% (average of 3 methods) values the shares at $249.79; the price of $555.80 is 123% above that value, and 67% of that value comes from beyond year five.
$249.79 per share (as of the 2026-10-19 close), against a market price of $555.80. That is a margin of safety of -122.5%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
75 out of 100, which we rate "Clear Leak", on 12 of 12 value investing signals.